Sutro Biopharma Inc

NASDAQ:STRO   3:59:50 PM EDT
19.08
+0.07 (+0.37%)
Products, Strategic Combinations

Sutro Biopharma And Bionova Pharmaceuticals Enter Into Collaboration For STRO-001 In Greater China

Published: 10/12/2021 11:23 GMT
Sutro Biopharma Inc (STRO) - Sutro Biopharma and Bionova Pharmaceuticals Enter Into Collaboration for Stro-001 in Greater China.
Sutro Biopharma Inc - Option Agreement for Bionova to Develop and Commercialize Stro-001, a Cd74-targeting Antibody-drug.
Sutro Biopharma Inc - Bionova Has Option to Obtain Exclusive Rights to Develop and Commercialize Stro-001 in Greater China.
Sutro Biopharma Inc - Bionova Will Pay to Sutro an Initial Licensing Option Payment of $4 Million, With Potential Payments Totaling Up to $200 Million.
Sutro Biopharma Inc - Sutro Will Provide Stro-001 to Bionova Under Appropriate Clinical and Commercial Supply Service Agreements.
Sutro Biopharma Inc - Upon Commercialization, Sutro Will Receive Tiered, Double-digit Royalties Based on Annual Net Sales of Stro-001 in Greater China.